Traditional Approaches to Androgen Deprivation TherapyMOUL, Judd W; EVANS, Christopher P; GOMELLA, Leonard G et al.Urology (Ridgewood, NJ). 2011, Vol 78, Num 5A, issn 0090-4295, S485-S493, SUPConference Paper

Embodied masculinity and androgen deprivation therapy = Masculinité personnifiée et thérapie de dépossession androgèneOLIFFE, John.Sociology of health & illness (Print). 2006, Vol 28, Num 4, pp 410-432, issn 0141-9889, 23 p.Article

DON'T THINK ONCE, THINK TWICE! THE CARDIOVASCULAR EFFECTS OF ANDROGEN DEPRIVATION THERAPYJEFFERIAES, Edward R; THURAIRAJA, Ramesh; PERSAD, Raj A et al.BJU international (Papier). 2011, Vol 107, Num 7, pp 1023-1028, issn 1464-4096, 6 p.Article

Androgen Deprivation Therapy and Cardiovascular RiskPUNNEN, Sanoj; COOPERBERG, Matthew R; SADETSKY, Natalia et al.Journal of clinical oncology. 2011, Vol 29, Num 26, pp 3510-3516, issn 0732-183X, 7 p.Article

Cardiovascular Morbidity Associated with Gonadotropin Releasing Hormone Agonists and an AntagonistALBERTSEN, Peter C; KLOTZ, Laurence; TOMBAL, Bertrand et al.European urology. 2014, Vol 65, Num 3, pp 565-573, issn 0302-2838, 9 p.Article

Patterns of androgen deprivation therapies among men diagnosed with localised prostate cancer: A population-based studyLYCKEN, Magdalena; GARMO, Hans; ADOLFSSON, Jan et al.European journal of cancer (1990). 2014, Vol 50, Num 10, pp 1789-1798, issn 0959-8049, 10 p.Article

The Impact of Dose-Escalated Radiotherapy Plus Androgen Deprivation for Prostate Cancer Using 2 Linked NomogramsSTOYANOVA, Radka; PAHLAJANI, Niraj H; EGLESTON, Brian L et al.Cancer. 2013, Vol 119, Num 5, pp 1080-1088, issn 0008-543X, 9 p.Article

Androgen Deprivation Therapy and Definitive Radiotherapy for Prostate CancerMENDENHALL, William M; HENDERSON, Randal H; HOPPE, Bradford S et al.American journal of clinical oncology. 2013, Vol 36, Num 5, pp 530-534, issn 0277-3732, 5 p.Article

Androgen deprivation therapy regulation of ss1C integrin expression in prostate cancerFUZIO, Paolo; LUCARELLI, Giuseppe; PERLINO, Elda et al.Oncology reports. 2009, Vol 22, Num 2, pp 327-335, issn 1021-335X, 9 p.Article

Androgen deprivation therapy affects BCL-2 expression in human prostate cancerFUZIO, Paolo; DITONNO, Pasquale; LUCARELLI, Giuseppe et al.International journal of oncology. 2011, Vol 39, Num 5, pp 1233-1242, issn 1019-6439, 10 p.Article

Bicalutamide-Associated Fulminant HepatotoxicityO'BRYANT, Cindy L; FLAIG, Thomas W; UTZ, Kenneth J et al.Pharmacotherapy. 2008, Vol 28, Num 8, pp 1071-1075, issn 0277-0008, 5 p.Article

Trends in the Use of Postprostatectomy Therapies for Patients With Prostate CancerSHEETS, Nathan C; HENDRIX, Laura H; ALLEN, Ian M et al.Cancer. 2013, Vol 119, Num 18, pp 3295-3301, issn 0008-543X, 7 p.Article

Weight Gain on Androgen Deprivation Therapy: Which Patients Are at Highest Risk?SEIBLE, Daniel M; XIANGMEI GU; TRINH, Quoc-Dien et al.Urology (Ridgewood, NJ). 2014, Vol 83, Num 6, pp 1316-1321, issn 0090-4295, 6 p.Article

Factors Associated With Reduction in Use of Neoadjuvant Androgen Suppression Therapy Before Radical ProstatectomyO'SHAUGHNESSY, Matthew J; JAROSEK, Stephanie L; VIRNIG, Beth A et al.Urology (Ridgewood, NJ). 2013, Vol 81, Num 4, pp 745-751, issn 0090-4295, 7 p.Article

Systemic bias in the medical literature on androgen deprivation therapy and its implication to clinical practicePHILLIPS, J. L; WASSERSUG, R. J; MCLEOD, D. L et al.International journal of clinical practice (Esher). 2012, Vol 66, Num 12, pp 1189-1196, issn 1368-5031, 8 p.Article

Enzalutamide (Xtandi) for Patients With Metastatic, Resistant Prostate CancerBENNETT, Lunawati L; INGASON, April.The Annals of pharmacotherapy. 2014, Vol 48, Num 4, pp 530-537, issn 1060-0280, 8 p.Article

Next-generation Sequencing of Advanced Prostate Cancer Treated with Androgen-deprivation TherapyRAJAN, Prabhakar; SUDBERY, Ian M; PONTING, Chris P et al.European urology. 2014, Vol 66, Num 1, pp 32-39, issn 0302-2838, 8 p.Article

Bone Density Testing Among Prostate Cancer Survivors Treated With Androgen-Deprivation TherapyMORGANS, Alicia K; SMITH, Matthew R; O'MALLEY, A. James et al.Cancer. 2013, Vol 119, Num 4, pp 863-870, issn 0008-543X, 8 p.Article

Patterns of Bone Mineral Density Testing in Men Receiving Androgen Deprivation for Prostate CancerSHAHINIAN, Vahakn B; KUO, Yong-Fang.Journal of general internal medicine. 2013, Vol 28, Num 11, pp 1440-1446, issn 0884-8734, 7 p.Article

The role of treatment modality on the utility of predictive tissue biomarkers in clinical prostate cancer: a systematic reviewKACHROO, Naveen; GNANAPRAGASAM, Vincent J.Journal of cancer research and clinical oncology. 2013, Vol 139, Num 1, pp 1-24, issn 0171-5216, 24 p.Article

Upfront Androgen Deprivation Therapy With Salvage Radiation May Improve Biochemical Outcomes in Prostate Cancer Patients With Post-Prostatectomy Rising PSAJANG, Joanne W; HWANG, Wei-Ting; GUZZO, Thomas J et al.International journal of radiation oncology, biology, physics. 2012, Vol 83, Num 5, pp 1493-1499, issn 0360-3016, 7 p.Article

Precursors of prostate cancerBOSTWICK, David G; LIANG CHENG.Histopathology. 2012, Vol 60, Num 1, pp 4-27, issn 0309-0167, 24 p.Article

Dose-Escalated Radiation Therapy for Intermediate-Risk Prostate Cancer : Patient Selection for Androgen Deprivation Therapy Using Percentage of Positive CoresLIAUW, Stanley L; FRICANO, Janine; CORREA, David et al.Cancer. 2009, Vol 115, Num 8, pp 1784-1790, issn 0008-543X, 7 p.Article

The HIF1 A functional genetic polymorphism at locus +1772 associates with progression to metastatic prostate cancer and refractoriness to hormonal castrationFRAGA, Avelino; RIBEIRO, Ricardo; MEDEIROS, Rui et al.European journal of cancer (1990). 2014, Vol 50, Num 2, pp 359-365, issn 0959-8049, 7 p.Article

Androgen deprivation therapy: evidence-based management of side effectsAHMADI, Hamed; DANESHMAND, Siamak.BJU international (Papier). 2013, Vol 111, Num 4, pp 543-548, issn 1464-4096, 6 p.Article